Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>EVAX is a clinical stage company that has proprietary AI models designed to more efficiently and more accurately target much-needed treatments.</li><li>The company has two streams of possible revenue: from the treatments themselves and from the licensing of the AI technology.</li><li> The company announced that its Phase 2 trial of its personalized cancer vaccine improved its response rate significantly from Phase I-both improving the chances for FDA approval and validating the AI approach to medicine.</li></ul>

EVAX is a clinical stage company that has proprietary AI models designed to more efficiently and more accurately target much-needed treatments.The company has two streams of possible revenue: from the treatments themselves and from the licensing of the AI technology. The company announced that its Phase 2 trial of its personalized cancer vaccine improved its response rate significantly from Phase I-both improving the chances for FDA approval and validating the AI approach to medicine.

EVAX:  Trial Suggests AI Improves Performance

Evaxion Biotech A/S

EVAX: Trial Suggests AI Improves Performance